CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3148
+0.0024 (0.77%)
At close: Jul 24, 2026, 4:00 PM EDT
0.3101
-0.0047 (-1.49%)
After-hours: Jul 24, 2026, 6:17 PM EDT

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $73.00K in the quarter ending March 31, 2026, a decrease of -96.45%. This brings the company's revenue in the last twelve months to $389.00K, down -84.26% year-over-year. In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth.

Revenue (ttm)
$389.00K
Revenue Growth
-84.26%
P/S Ratio
15.30
Revenue / Employee
$9,974
Employees
39
Market Cap
5.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.37M1.86M360.39%
Dec 31, 2024515.00K-10.44M-95.30%
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 20206.14M3.82M164.75%
Dec 31, 20192.32M-2.70M-53.77%
Dec 31, 20185.01M4.55M982.94%
Dec 31, 2017463.00K387.12K510.15%
Dec 31, 201675.88K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xenetic Biosciences3.19M
BioAtla2.00M
Evogene1.84M
Addex Therapeutics136.51K
Pulmatrix3.00K
Revenue Rankings